PDLI Related FDA

Jun 19, 2012 07:04 AM PDL BioPharma (PDLI) to Receive Royalties from Perjeta Sales (RHHBY)

Jul 11, 2011 07:09 AM PDL BioPharma (PDLI) Receives Favorable Ruling Against Roche's (RHHBY) Genentech

Feb 28, 2011 07:17 AM EPO Upholds PDL BioPharma's (PDLI) 216B Patent

Feb 16, 2011 07:12 AM PDL (PDLI) To Pay $92.5M in Settlement with MedImmune

Jan 5, 2009 09:07 AM Alexion Pharmaceuticals (ALXN) and PDL BioPharma (PDLI) Resolve Patent Dispute

Aug 19, 2008 04:03 PM Bristol-Myers Squibb (BMY) and PDL BioPharma (PDLI) Enter Agreement

Jan 8, 2008 09:06 AM Ophthotech, Biogen Idec (BIIB) and PDL BioPharma (PDLI) in Agreement For AMD Treatment

Dec 19, 2006 07:53 AM PDL BioPharma (PDLI) and Orphan Therapeutics End Terlipressin Agreement

Dec 5, 2006 01:48 PM Needham Highlights Biotech Companies Presenting at the Upcoming American Society of Hematology

Aug 30, 2006 09:03 AM PDL BioPharma (PDLI) Says Roche Discontinues Involvement in Development of Daclizumab

Mar 23, 2006 04:24 PM PDL BioPharma (PDLI) Says Partner, Orphan Therapeutics, Completes Enrollment of Phase III Study of Terlipressin

Jan 3, 2006 04:05 PM PDLI Grants Patent Licenses to Merck

Sep 12, 2005 04:10 PM PDLI Announces Successful Closing of Global Alliance With BIIB

Aug 22, 2005 11:33 AM PDLI Announces Positive Phase 2 Data for Ularitide

Aug 2, 2005 04:17 PM BIIB and PDLI Enter Broad Collaboration

Jun 22, 2005 08:13 AM PDLI Sublicenses Rights to Develop Antibody-Drug Conjugates for Prostate Cancer to DNA

Apr 18, 2005 08:10 AM PDLI Reports Positive Phase II Results

Mar 23, 2005 08:14 AM PDLI Reports on Nuvion Meeting Held With the FDA

Feb 28, 2005 11:26 AM PDLI Victim of Tysabri Fallout